43-year old patient presents to your clinic for an appointment. She has mild hypertension, which is currently well controlled with a ß-blocker. She was diagnosed with type 2 diabetes 6-years ago, and has been taking metformin and glipizide. She has noticed that her recent self-blood glucose monitoring numbers have been creeping up and with a most recent FPG of 160 mg/dl. At today’s visit, she has an A1C 8.0%. She tells you that until now her job has required she travel several times a month. This week she was promoted to a managerial position that does not require travel. Which of the following approaches would be the best for her?

Just for fun, here's a bonus question to Test Your Knowledge of Thanksgiving: according to food historians, the meal at the first Thanksgiving in 1621 would have been very different from what most U.S. celebrants eat today. In fact, only one of these modern Thanksgiving staples might actually have been on the table back then. Which one is it?

Those of us in the U.S. celebrated Thanksgiving this week. One of the things the DIC team has to be thankful for is our wonderful readers. We’re grateful for your loyal readership and especially for the great feedback and content, like our weekly Disasters Averted stories, you send us. We …

These were the Test Your Knowledge questions that generated the most interest for Diabetes In Control readers in 2015. See how many you remember! [QTL-Question id=29] [QTL-Question id=30] [QTL-Question id=31] [QTL-Question id=32] [QTL-Question id=33]

When you do the math, 95% of all diabetes patients have type 2. This does not mean that we should ignore type 1 patients when looking at psychological problems; in fact, most of the information on these problems deals with type 1 patients. These problems can include development of diabetes, …

Much of the literature concerns the important problem of type 2 diabetes and depression and, in comparison with type 1 diabetes, little about the psychological disturbances associated with specific phases of type 2 diabetes.

In this week's Homerun Slides, the results of lowering plasma glucose concentration with dapagliflozin.

Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. In this final installment, Dr. Hirsch summarizes his ADA 2015 presentation, including a comparison of the BD infusion set to the current popular model, and images showing the fluid within infusion sets as captured by MRI and ultrasound.

Study results indicate that risk increased similarly for all glucose lowering agents.

FACT: Up to two-thirds of eligible Hispanics are not taking statins.